The prevalence of obesity in the United States has risen gradually over the past decade. As of 2023, around ** percent of the population aged 18 years and older was obese. Obesity is a growing problem in many parts of the world, but is particularly troubling in the United States. Obesity in the United States The states with the highest prevalence of obesity are West Virginia, Mississippi, and Arkansas. As of 2023, a shocking ** percent of the population in West Virginia were obese. The percentage of adults aged 65 years and older who are obese has grown in recent years, compounding health issues that develop with age. Health impacts of obesity Obesity is linked to several negative health impacts including cardiovascular disease, diabetes, and certain types of cancer. Unsurprisingly, the prevalence of diagnosed diabetes has increased in the United States over the years. As of 2022, around *** percent of the population had been diagnosed with diabetes. Some of the most common types of cancers caused by obesity include breast cancer in postmenopausal women, colon and rectum cancer, and corpus and uterus cancer.

Between 2015 and 2018, obesity rates in U.S. children and adolescents stood at 19.3 and 20.9 percent, respectively. This is a noteworthy increase compared to the percentages seen between 1988 and 1994.

U.S. high school obesity rates

Roughly 18 percent of black, as well as Hispanic students in the United States, were obese between 2016 and 2017. Male obesity rates were noticeably higher than those of female students for each of the ethnicities during the measured period. For example, about 22 percent of male Hispanic high school students were obese, compared to 14 percent of female students. The American states with the highest number of obese high school students in 2019 included Mississippi, West Virginia, and Arkansas, respectively. Mississippi had a high school student obesity rate of over 23 percent that year.

Physically inactive Americans

Adults from Mississippi and Arkansas were also reported to be some of the least physically active people in the United States in 2018. When surveyed, over 30 percent of adults from Kentucky and Arkansas had not exercised within the preceding 30 days. The national physical inactivity average stood at approximately 26 percent that year.

In 2023, it was estimated that around 37 percent of adults with an annual income of less than 15,000 U.S. dollars were obese, compared to 29 percent of those with an annual income of 75,000 dollars or more. This statistic shows the percentage of U.S. adults who were obese in 2023, by income.

West Virginia, Mississippi, and Arkansas are the U.S. states with the highest percentage of their population who are obese. The states with the lowest percentage of their population who are obese include Colorado, Hawaii, and Massachusetts. Obesity in the United States Obesity is a growing problem in many countries around the world, but the United States has the highest rate of obesity among all OECD countries. The prevalence of obesity in the United States has risen steadily over the previous two decades, with no signs of declining. Obesity in the U.S. is more common among women than men, and overweight and obesity rates are higher among African Americans than any other race or ethnicity. Causes and health impacts Obesity is most commonly the result of a combination of poor diet, overeating, physical inactivity, and a genetic susceptibility. Obesity is associated with various negative health impacts, including an increased risk of cardiovascular diseases, certain types of cancer, and diabetes type 2. As of 2022, around 8.4 percent of the U.S. population had been diagnosed with diabetes. Diabetes is currently the eighth leading cause of death in the United States.

In 2023, Black adults had the highest obesity rates of any race or ethnicity in the United States, followed by American Indians/Alaska Natives and Hispanics. As of that time, around ** percent of all Black adults were obese. Asians/Pacific Islanders had by far the lowest obesity rates. Obesity in the United States Obesity is a present and growing problem in the United States. An astonishing ** percent of the adult population in the U.S. is now considered obese. Obesity rates can vary substantially by state, with around ** percent of the adult population in West Virginia reportedly obese, compared to ** percent of adults in Colorado. The states with the highest rates of obesity include West Virginia, Mississippi, and Arkansas. Diabetes Being overweight and obese can lead to a number of health problems, including heart disease, cancer, and diabetes. Being overweight or obese is one of the most common causes of type 2 diabetes, a condition in which the body does not use insulin properly, causing blood sugar levels to rise. It is estimated that just over ***** percent of adults in the U.S. have been diagnosed with diabetes. Diabetes is now the seventh leading cause of death in the United States, accounting for ***** percent of all deaths.

Data on normal weight, overweight, and obesity among adults aged 20 and over by selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder (https://www.cdc.gov/nchs/hus/contents2019.htm) for critical information about measures, definitions, and changes over time.

SOURCE: NCHS, National Health and Nutrition Examination Survey. For more information on the National Health and Nutrition Examination Survey, see the corresponding Appendix entry at https://www.cdc.gov/nchs/data/hus/hus19-appendix-508.pdf.

In 2022, the prevalence of diagnosed diabetes in the United States among people aged 18 and over amounted to 8.4 percent.

How many people in the United States have diabetes? It was estimated that in 2022, around 24.4 million people in the United States had been diagnosed with diabetes. The number of people living with diabetes has increased over the past few decades, with only five million people living with diabetes in the year 1980. Diabetes in the United States is more common among older adults with around 24 percent of those aged 65 years and older diagnosed with diabetes, compared to 15 percent of those aged 45 to 64 years.

Leading diabetic states

In 2021, the U.S. states with the highest prevalence of diagnosed diabetes were Alabama, Mississippi, and West Virginia, respectively. Just over 17 percent of adults in Alabama had diabetes that year. Roughly 14 percent of adults in Georgia had been diagnosed with diabetes before or during the measured period, putting the state of Georgia in tenth place.

BackgroundUnderstanding the social environmental around obesity has been limited by available data. One promising approach used to bridge similar gaps elsewhere is to use passively generated digital data.PurposeThis article explores the relationship between online social environment via web-based social networks and population obesity prevalence.MethodsWe performed a cross-sectional study using linear regression and cross validation to measure the relationship and predictive performance of user interests on the online social network Facebook to obesity prevalence in metros across the United States of America (USA) and neighborhoods within New York City (NYC). The outcomes, proportion of obese and/or overweight population in USA metros and NYC neighborhoods, were obtained via the Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance and NYC EpiQuery systems. Predictors were geographically specific proportion of users with activity-related and sedentary-related interests on Facebook.ResultsHigher proportion of the population with activity-related interests on Facebook was associated with a significant 12.0% (95% Confidence Interval (CI) 11.9 to 12.1) lower predicted prevalence of obese and/or overweight people across USA metros and 7.2% (95% CI: 6.8 to 7.7) across NYC neighborhoods. Conversely, greater proportion of the population with interest in television was associated with higher prevalence of obese and/or overweight people of 3.9% (95% CI: 3.7 to 4.0) (USA) and 27.5% (95% CI: 27.1 to 27.9, significant) (NYC). For activity-interests and national obesity outcomes, the average root mean square prediction error from 10-fold cross validation was comparable to the average root mean square error of a model developed using the entire data set.ConclusionsActivity-related interests across the USA and sedentary-related interests across NYC were significantly associated with obesity prevalence. Further research is needed to understand how the online social environment relates to health outcomes and how it can be used to identify or target interventions.

In Mississippi, over seven out of ten adults were reported to be either overweight or obese in 2018, making it the leading U.S. state that year. Other prominent states, in terms of overweight and obesity, included Arkansas in fourth, Oklahoma in seventh, and Louisiana in tenth place.

Corpulence per state

When it comes to obesity, specifically, percentages were still very high for certain states. Almost forty percent of West Virginia’s population was obese in 2018. Colorado, Hawaii, and California were some of the healthier states that year, with obesity rates between 22 and 25 percent. The average for the country itself stood at just over 31 percent.

Obesity-related health problems

Being obese can lead to various health-related complications, such as diabetes and diseases of the heart. In 2017, almost 22 people per 100,000 died of diabetes mellitus in the United States. In the same year, roughly 165 per 100,000 Americans died of heart disease. While the number of deaths caused by heart disease has decreased significantly over the past sixty to seventy years, it is still one of the leading causes of death in the country.

Objective and aimsIdentification of associations between the obese category of weight in the general US population will continue to advance our understanding of the condition and allow clinicians, providers, communities, families, and individuals make more informed decisions. This study aims to improve the prediction of the obese category of weight and investigate its relationships with factors, ultimately contributing to healthier lifestyle choices and timely management of obesity.MethodsQuestionnaires that included demographic, dietary, exercise and health information from the US National Health and Nutrition Examination Survey (NHANES 2017–2020) were utilized with BMI 30 or higher defined as obesity. A machine learning model, XGBoost predicted the obese category of weight and Shapely Additive Explanations (SHAP) visualized the various covariates and their feature importance. Model statistics including Area under the receiver operator curve (AUROC), sensitivity, specificity, positive predictive value, negative predictive value and feature properties such as gain, cover, and frequency were measured. SHAP explanations were created for transparent and interpretable analysis.ResultsThere were 6,146 adults (age > 18) that were included in the study with average age 58.39 (SD = 12.94) and 3122 (51%) females. The machine learning model had an Area under the receiver operator curve of 0.8295. The top four covariates include waist circumference (gain = 0.185), GGT (gain = 0.101), platelet count (gain = 0.059), AST (gain = 0.057), weight (gain = 0.049), HDL cholesterol (gain = 0.032), and ferritin (gain = 0.034).ConclusionIn conclusion, the utilization of machine learning models proves to be highly effective in accurately predicting the obese category of weight. By considering various factors such as demographic information, laboratory results, physical examination findings, and lifestyle factors, these models successfully identify crucial risk factors associated with the obese category of weight.

Maternal obesity has been associated with a higher risk of pregnancy-related complications in mothers and offspring; however, effective interventions have not yet been developed. We tested two common interventions, calorie restriction and pravastatin administration, during pregnancy in a rhesus macaque model with the hypothesis that these interventions would normalize metabolic dysregulation in pregnant mothers leading to an improvement in infant metabolic and cognitive/social development. A total of 19 obese mothers were assigned to either one of the two intervention groups (n=5 for calorie restriction; n=7 for pravastatin) or an obese control group (n=7) with no intervention, and maternal gestational samples and postnatal infant samples were compared with lean control mothers (n=6). Gestational calorie restriction normalized one-carbon metabolism dysregulation in obese mothers but altered energy metabolism in their offspring. Although administration of pravastatin during pregnancy tended to normalize blood cholesterol in the mothers, it potentially impacted the gut microbiome and kidney function of their offspring. In the offspring, both calorie restriction and pravastatin administration during pregnancy tended to normalize the activity of AMPK in the brain at 6 months, and while results of the Visual Paired-Comparison test, which measures infant recognition memory, were not significantly impacted by either of the interventions, gestational pravastatin administration, but not calorie restriction, tended to normalize anxiety assessed by the Human Intruder test. Although the two interventions tested in a non-human primate model led to some improvements in metabolism and/or infant brain development, negative impacts were also found in both mothers and infants. Our study emphasizes the importance of assessing gestational interventions for maternal obesity on both maternal and offspring long-term outcomes. Methods Study population Pregnant female rhesus macaques (Macaca mulatta) from an indoor breeding colony at the California National Primate Research Center with appropriate social behavior and previous successful pregnancies were enrolled. Animal handling was approved by the UC Davis Institutional Animal Care and Use Committee (IACUC) (#19299). A qualitative real-time PCR assay (Jimenez & Tarantal, 2003) was used to identify mothers with male fetuses to include in this study. Since obesity is defined as subjects with body fat above 30% for women, according to guidelines from the American Society of Bariatric Physicians, American Medical Association, and in some publications (Okorodudu et al., 2010; Shah & Braverman, 2012), a Body Condition Score (BCS) of 3.5 (32.8 % body fat on average (Summers et al., 2012)) was used as the cutoff. Therefore, mothers with BCS of 3.5 and above were categorized as obese. Obese mothers were randomly assigned to the Obese Control (OC) group, OR group (received calorie Restriction), or OP group (received Pravastatin). Mothers with BCS of 2.5 and below were assigned to the Lean Control (LC) group. The unbalanced sample size was because some mothers were removed from the analyses due to fetal deaths for unknown reasons, misidentification of a female fetus, different timing for study enrollment, or technical issues upon collecting samples. The number of animals was six for the LC, seven for the OC, five for the OR, and seven for the OP groups. Feeding, rearing, and interventions Adult female animals were provided monkey diet (High Protein Primate Diet Jumbo #5047; LabDiet, St. Louis, MO, USA) twice a day between 6–9 am and 1–3 pm. The calories were provided as 56% from carbohydrates, 30% from protein, and 13% from. Mothers in the LC, OC, and OP groups were fed nine biscuits twice a day once pregnancy was confirmed. Mothers in the OR group received a restricted supply of food once the pregnancy was detected and was maintained throughout pregnancy. The food restriction was set such that the average total weight increase would be 8% body weight from the last day before conception because the recommended total weight gain in the 2nd and 3rd trimesters is 5-9 kg for the average US woman with obesity who weighs 80 kg and is 1.6 m in height (Body Mass Index of 30), according to the Institute of Medicine 2009 guidelines (Institute of Medicine and National Research Council, 2009). During nursing of infants older than 4 months, all mothers were provided twelve biscuits. Fresh produce was provided biweekly, and water was provided ad libitum for all mothers. Mothers in the OP group were given pravastatin sodium (ApexBio Technology, Houston, TX, USA) at 20 mg/kg body weight prepared in a neutralized syrup (20 mg/mL sodium bicarbonate dissolved in a fruit-flavored syrup (Torani, San Leandro, CA, USA)) once a day from the time pregnancy was confirmed until delivery. The caloric value of the administration was made so as not to influence body weight or skew nutritional value of the diet among all treatment groups. Both interventions were applied only during gestation. Although most mothers were allowed to deliver naturally, cesarean delivery was performed for fetal indications when recommended by veterinarians (2 for each of the LC and OC groups, and 1 for the OP group). These mothers did not accept their infant following birth, so foster mothers were provided. Sample Collection and pre-processing prior to sample storage The animal caretakers and researchers who collected samples were blinded for group assignment by coding all animals by IDs. The collected biological samples were randomized by using random numbers and the group assignment was blinded during the data collection. Both mothers (during pregnancy) and infants were weighed every week. One day before sample collection, food was removed 30 min after the afternoon feeding, and biological samples were collected prior to the morning feeding. To collect biological samples, animals were anesthetized using 5–30 mg/kg ketamine or 5–8 mg/kg telazol. Both maternal and infant blood was collected using 5 mL lavender top (EDTA) tubes (Monoject, Cardinal Health, Dublin, OH, USA) and urine was collected from the bladder by ultrasound-guided transabdominal cystotomy using a 22-gauge needle and stored in a 15 mL Falcon tube. A placental sample was collected at GD150 transabdominally under ultrasound guidance using an 18-gauge needle attached to a sterile syringe. Sample processing was as previously described in (Hasegawa et al., 2022). Necropsy was conducted between 9:30 am–1:30 pm. First, infants at the age of PD180 were fasted and anesthetized with ketamine, and plasma and urine were collected. Then, euthanasia was performed with 120 mg/kg pentobarbital, followed by heparin injection, clamping of the descending aorta, and flushing with saline until clear. The kidney and brain (amygdala, hippocampus, hypothalamus, and prefrontal cortex) were collected, weighed, and immediately frozen on dry ice or liquid nitrogen to store at -80 °C until further analyses. Metabolite extraction and analysis by 1H NMR, and measurement of insulin, cholesterol, cytokine, and cortisol Detailed procedures were previously described (Hasegawa et al., 2022). Briefly, plasma and urine samples were filtered using Amicon Ultra Centrifugal Filter (3k molecular weight cutoff; Millipore, Billerica, MA, USA), and the supernatant was used for analysis. For both the placental and brain tissue samples, polar metabolites were extracted using our previously reported method (Hasegawa et al., 2020). A total of 180 μL of sample (tissue extract or filtered urine or serum) was transferred to 3 mm Bruker NMR tubes (Bruker, Billerica, MA, USA). Within 24 h of sample preparation, all 1H NMR spectra were acquired using the noesypr1d pulse sequence on a Bruker Avance 600 MHz NMR spectrometer (Bruker, Billerica, MA, USA) (O’Sullivan et al., 2013). Chenomx NMRSuite (version 8.1, Chenomx Inc., Edmonton, Canada) (Weljie et al., 2006) was used to identify and quantify metabolites. Heparin-treated plasma samples were used to measure insulin and 17 cytokines and chemokines (hs-CRP, Granulocyte-macrophage colony-stimulating factor, IFN-γ, TNF-α, transforming growth factor-α, monocyte chemoattractant protein-1, macrophage inflammatory protein-1β (MIP-1β), and interleukin (IL)-1β, IL-1 receptor antagonist (IL-1ra), IL-2, IL-6, IL-8, IL-10, IL-12/23 p40, IL-13, IL-15, and IL-17A) using a multiplex Bead-Based Kit (Millipore) on a Bio-Plex 100 (Bio-rad, Hercules, CA) following the manufacturer’s protocol. For each sample, a minimum of fifty beads per region were collected and analyzed with Bio-Plex Manager software using a 5-point standard curve with immune marker quantities extrapolated based on the standard curve. Two samples were removed for analysis of TNF-α and IL-1ra as technical errors (both from Animal ID 1132103: 895.2 and 1115.1 pg/mL at gestational days (GD) 90; 510.8 and 617.2 pg/mL at GD120, respectively). Plasma cholesterol level was measured by Clinical Laboratory Diagnostic Product (OSR6116) on Beckman Coulter AU480 (Beckman Coulter, Brea, CA). Infant plasma cortisol level at PD110 was assessed as previously described (Vandeleest et al., 2019; Walker et al., 2018). In short, infants were transferred to a test room at 9 am and blood was drawn at 11 am (Sample 1), followed by another blood collection at 4 pm (Sample 2) and intramuscular injection of 500 μg/kg dexamethasone (Dex) (American Regent Laboratories, Inc., Shirley, NY). On the next day, a blood sample was collected at 8:30 am (Sample 3), and then 2.5 IU of adrenocorticotropic hormone (Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA) was injected intramuscularly. The last blood was collected (Sample 4) 30 min after adrenocorticotropic hormone injection. The collected blood samples were processed and stored, and cortisol concentration was assessed by a chemiluminescent assay on the ADVIA Centaur CP platform

BackgroundFood insecurity, the uncertain ability to access adequate food, can limit adherence to dietary measures needed to prevent and manage cardiometabolic conditions. However, little is known about temporal trends in food insecurity among those with diet-sensitive cardiometabolic conditions.MethodsWe used data from the Continuous National Health and Nutrition Examination Survey (NHANES) 2005–2012, analyzed in 2015–2016, to calculate trends in age-standardized rates of food insecurity for those with and without the following diet-sensitive cardiometabolic conditions: diabetes mellitus, hypertension, coronary heart disease, congestive heart failure, and obesity.Results21,196 NHANES participants were included from 4 waves (4,408 in 2005–2006, 5,607 in 2007–2008, 5,934 in 2009–2010, and 5,247 in 2011–2012). 56.2% had at least one cardiometabolic condition, 24.4% had 2 or more, and 8.5% had 3 or more. The overall age-standardized rate of food insecurity doubled during the study period, from 9.06% in 2005–2006 to 10.82% in 2007–2008 to 15.22% in 2009–2010 to 18.33% in 2011–2012 (p for trend < .001). The average annual percentage change in food insecurity for those with a cardiometabolic condition during the study period was 13.0% (95% CI 7.5% to 18.6%), compared with 5.8% (95% CI 1.8% to 10.0%) for those without a cardiometabolic condition, (parallelism test p = .13). Comparing those with and without the condition, age-standardized rates of food insecurity were greater in participants with diabetes (19.5% vs. 11.5%, p < .0001), hypertension (14.1% vs. 11.1%, p = .0003), coronary heart disease (20.5% vs. 11.9%, p < .001), congestive heart failure (18.4% vs. 12.1%, p = .004), and obesity (14.3% vs. 11.1%, p < .001).ConclusionsFood insecurity doubled to historic highs from 2005–2012, particularly affecting those with diet-sensitive cardiometabolic conditions. Since adherence to specific dietary recommendations is a foundation of the prevention and treatment of cardiometabolic disease, these results have important implications for clinical management and public health.

NA: Not applicable, for cells where the zero percent of the population fell into that category.(1) Prevalences and standard errors are calculated using the survey weights from the 5-year visit provided with the dataset. These adjust for unequal probability of selection and response. Survey and subclass estimation commands were used to account for complex sample design.(2) Overweight/obesity is defined as body mass index (BMI) z-score >2 standard deviations (SD) above age- and sex- specific WHO Childhood Growth Standard reference mean at all time points except birth, where we define overweight/obesity as weight-for-age z-score >2 SD above age- and sex- specific WHO Childhood Growth Standard reference mean.(3) To represent socioeconomic status, we used a composite index to capture multiple of the social dimensions of socioeconomic status. This composite index was provided in the ECLS-B data that incorporates information about maternal and paternal education, occupations, and household income to create a variable representing family socioeconomic status on several domains. The variable was created using principal components analysis to create a score for family socioeconomic status, which was then normalized by taking the difference between each score and the mean score and dividing by the standard deviation. If data needed for the composite socioeconomic status score were missing, they were imputed by the ECLS-B analysts [9].(4) We created a 5-category race/ethnicity variable (American Indian/Alaska Native, African American, Hispanic, Asian, white) from the mothers' report of child's race/ethnicity, which originally came 25 race/ethnic categories. To have adequate sample size in race/ethnic categories, we assigned a single race/ethnic category for children reporting more than one race, using an ordered, stepwise approach similar to previously published work using ECLS-B (3). First, any child reporting at least one of his/her race/ethnicities as American Indian/Alaska Native (AIAN) was categorized as AIAN. Next, among remaining respondents, any child reporting at least one of his/her ethnicities as African American was categorized as African American. The same procedure was followed for Hispanic, Asian, and white, in that order. This order was chosen with the goal of preserving the highest numbers of children in the American Indian/Alaska Native group and other non-white ethnic groups in order to estimate relationships within ethnic groups, which is often not feasible due to low numbers.

Approximately 40% of the U.S. adult population are obese. An issue associated with this trend is proper seat belt fit for obese occupants. This study extends previous research, in which few individuals with high BMI (> 40 kg/m2) were included, by examining the relationship between participant and belt factors on belt fit for drivers with Class I-III obesity. Posture and belt fit of 52 men and women with BMI from 31 to 59 kg/m2 (median 38 kg/m2) were measured in a laboratory vehicle mockup. Five seat belt configurations were achieved by manipulating the belt anchorage locations. Body and belt landmark locations were recorded using a three-dimensional coordinate measuring machine. Higher BMI was associated with a lap belt position further forward and higher relative to the pelvis. On average, the lap belt was positioned an additional 32 mm forward and 13 mm above the ASIS with each increasing level of obesity classification. Sex had a small effect after accounting for BMI and stature. The mean fore-aft location of the lap belt was 24 mm more forward for men vs. women and 12 mm higher for women vs. men at the same stature and BMI. On average, women used 50 mm more belt webbing in the lap and 92 mm more in the shoulder vs. men. The results suggest that increasing levels of obesity class effectively introduces slack in the seat belt system by routing the belt further away from the skeleton. Because the belt is designed to engage the pelvis during a frontal crash, belt placements that are higher and further forward may increase injury risk by allowing excursions or submarining. Unique to this cohort, sex had an important effect on belt fit measures after taking into account stature and BMI. The participant and belt factors considered explained only about 40% of the variance in belt fit. The remaining variance may be due to preference or exogenous body shape effects. Further research is needed to assess methods for enhanced seat belt fit for people with obesity, including addressing sex differences in belt routing.

This table contains data on the average cost of a market basket of nutritious food items relative to income for female-headed households with children, for California, its regions, counties, and cities/towns. The ratio uses data from the U.S. Department of Agriculture and the U.S. Census Bureau. The table is part of a series of indicators in the Healthy Communities Data and Indicators Project of the Office of Health Equity. An adequate, nutritious diet is a necessity at all stages of life. Inadequate diets can impair intellectual performance and have been linked to more frequent school absence and poorer educational achievement in children. Nutrition also plays a significant role in causing or preventing a number of illnesses, such as cardiovascular disease, some cancers, obesity, type 2 diabetes, and anemia. At least two factors influence the affordability of food and the dietary choices of families – the cost of food and family income. The inability to afford food is a major factor in food insecurity, which has a spectrum of effects including anxiety over food sufficiency or food shortages; reduced quality or desirability of diet; and disrupted eating patterns and reduced food intake. More information about the data table and a data dictionary can be found in the Attachments.

Gym and exercise equipment producers have faced moderate volatility in recent years. Manufacturers have benefited from consumers becoming more health-conscious, pushing them to care for their health through sports and exercise and boosting equipment sales. This shift in consumer behavior has allowed demand for gyms and fitness centers to jump, while more people doing at-home workouts have supported demand from the individual market. Although unfavorable macroeconomic conditions, including elevated inflation and weaker disposable income, have pushed consumers to prioritize essential purchases and caused sales to weaken in 2021 and 2024, these revenue losses have not reversed 2021 gains. These trends will cause revenue to grow at an estimated CAGR of 3.6% to $3.6 billion through 2025, including a 1.6% drop that year alone. Globalization trends have demand for domestic equipment manufacturers, as foreign manufacturers produce gym and exercise equipment at far lower costs. Offshoring manufacturing capabilities have become increasingly prevalent to lower production and labor costs. Many prominent companies have enlisted foreign third-party manufacturers or moved their operations overseas to lower production costs. Uneven domestic demand has encouraged manufacturers to focus on international markets as innovative gym and exercise equipment has attracted consumers to US-made products and mitigated some import penetration. However, the US Government has been implementing increasingly strict protectionary measures, including possible tariffs on major trade partners (including Canada and Mexico), creating more uncertainty around the industry. Moving forward, demand for exercise equipment will continue to grow, although at a slower rate. The expected depreciation of the US dollar is forecast to boost domestic machinery sales as US-produced equipment becomes comparatively more affordable. Stabilizing economic conditions will result in falling steel prices and lower operating expenses. These trends are set to boost revenue and make manufacturers more profitable. Profit will also benefit from the weaker import penetration, enabling manufacturers to allocate more resources to research and development expenditure to drive innovation. However, producers will face significant uncertainty surrounding trade activity over the coming years, impacting their purchase costs for producers that import inputs and their performance, both domestically and internationally. Revenue is set to grow at an estimated CAGR of 1.6% to $3.9 billion through the end of 2030.

Personal trainers operate in two general areas: the most prominent segment is in gyms and other fitness centers. In contrast, the other segment is in-house operations, tailoring workouts and regiments to the individual client and their needs at home. This industry derives demand from downstream consumer groups. The group with the highest demand for personal trainer services are the 35- to 50-year-old consumers. Because of the nature of the industry, consumers with a higher per capita disposable income are more likely to purchase discretionary goods, with some personal training sessions topping over $100 per hour. Overall, revenue for personal trainers is expected to expand at a CAGR of 3.3% to $12.9 billion through the end of 2024, when profit is set to reach 12.8%. The industry adapted during the pandemic as trainers were able to adjust and start doing online workouts. This adaptation saved the industry from much more significant losses in 2020. At the end of this period, rising inflation and interest rates caused another slight drop of 0.8% in revenue in 2024, as consumers have less disposable income, decreasing demand for discretionary purchases, like personal trainers. The economic issues plaguing the last period are expected to dissipate by the end of 2029, resulting in a rebound. Economic conditions are expected to level off by the end of 2029, bringing back demand for discretionary purchases. In addition to this, obesity rates across the US are set to climb, bolstering the need for personal training services for several age groups. Overall, revenue for personal trainers is expected to rise at a CAGR of 1.1% to $13.7 billion through the end of 2029.

a For BMI, BAZ and overweight & obesity prevalence, the ‘effect’ means BMI, BAZ and overweight & obesity prevalence reduction (post intervention vs before intervention) in intervention group compared with that of in the control group, respectively. b ALL CER was presented in US dollars. c O & B means overweight & obesity. d Total’ means the average effect of four intervention centers (Jinan, Guangzhou, Harbin, Shanghai), Chongqing was excluded here because the intervention in this city was not effective (p>0.05).

The podiatrist industry is witnessing a dynamic shift driven by demographic changes and evolving patient needs. Obesity and an aging population are key factors driving more individuals to seek foot-related medical services. Podiatrists now see an increasing number of patients with diabetes-related foot issues, highlighting a growing demand for specialized care. This surge correlates with the aging baby boomer generation, who require more frequent medical oversight for chronic conditions. The industry strives to offer comprehensive care solutions, resulting in a higher workload and the necessity for advanced treatment options. Multispecialty partnerships within the field are becoming pivotal, fostering holistic patient management and enhancing care quality through collaborative efforts with other healthcare providers. Revenue is projected to increase at a compound annual growth rate (CAGR) of 2.8% to reach $7.3 billion by 2025, rising 2.8% in 2025 alone. Over the past five years, industry performance has varied across different practice sizes and locations. Larger practices, benefiting from economies of scale and advanced technologies, have managed to sustain profitability. They effectively distribute labor and negotiate favorable supplier terms, contributing to financial stability. Smaller offices face challenges because of limited resources, high labor costs and the inability to invest in essential upgrades. Regional disparities are evident, with rural podiatrists enjoying higher net income because of lower overheads and reduced competition. Partnerships have emerged as a strategic advantage, enhancing service offerings and patient base diversity. Despite steady marketing expenses and predictable costs like depreciation, solo practitioners grapple with high rental rates and insurance expenses, affecting their competitive edge. Over the next five years, the podiatrist industry anticipates continued growth, propelled by chronic disease prevalence and an aging population. As awareness regarding the connection between foot health and overall wellness expands, patient visits are expected to rise, driving practices to enhance their outreach strategies. The sector may face challenges as Medicare reimbursement reductions impact profit, leading some to seek alternative funding methods. Larger group practices likely will continue to gain prominence, leveraging resources and diversifying funding sources, while solo practitioners remain integral for personalized services. Efforts by industry associations to advocate for better insurance alignment could improve service access and patient trust, positioning podiatrists as essential healthcare contributors. Revenue is projected to grow at a CAGR of 1.6% to reach $7.9 billion by 2030.

This multi-scale map shows life expectancy - a widely-used measure of health and mortality. From the County Health Rankings page about Life Expectancy:"Life Expectancy is an AverageLife Expectancy measures the average number of years from birth a person can expect to live, according to the current mortality experience (age-specific death rates) of the population. Life Expectancy takes into account the number of deaths in a given time period and the average number of people at risk of dying during that period, allowing us to compare data across counties with different population sizes.Life Expectancy is Age-AdjustedAge is a non-modifiable risk factor, and as age increases, poor health outcomes are more likely. Life Expectancy is age-adjusted in order to fairly compare counties with differing age structures.What Deaths Count Toward Life Expectancy?Deaths are counted in the county where the individual lived. So, even if an individual dies in a car crash on the other side of the state, that death is attributed to his/her home county.Some Data are SuppressedA missing value is reported for counties with fewer than 5,000 population-years-at-risk in the time frame.Measure LimitationsLife Expectancy includes mortality of all age groups in a population instead of focusing just on premature deaths and thus can be dominated by deaths of the elderly.[1] This could draw attention to areas with higher mortality rates among the oldest segment of the population, where there may be little that can be done to change chronic health problems that have developed over many years. However, this captures the burden of chronic disease in a population better than premature death measures.[2]Furthermore, the calculation of life expectancy is complex and not easy to communicate. Methodologically, it can produce misleading results caused by hidden differences in age structure, is sensitive to infant and child mortality, and tends to be overestimated in small populations."Breakdown by race/ethnicity in pop-up: (This map has been updated with new data, so figures may vary from those in this image.)There are many factors that play into life expectancy: rates of noncommunicable diseases such as cancer, diabetes, and obesity, prevalence of tobacco use, prevalence of domestic violence, and many more.Proven strategies to improve life expectancy and health in general A database of dozens of strategies can be found at County Health Rankings' What Works for Health site, sorted by Health Behaviors, Clinical Care, Social & Economic Factors, and Physical Environment. Policies and Programs listed here have been evaluated as to their effectiveness. For example, consumer-directed health plans received an evidence rating of "mixed evidence" whereas cultural competence training for health care professionals received a rating of "scientifically supported." Data from County Health Rankings (layer referenced below), available for nation, state, and county, and available in ArcGIS Living Atlas of the World.